HDRP Newsletter, December 2015
- Message from Acting Associate Director, Ann Geiger
- Spotlight on…
- Working for You…
- Current Funding Opportunities
- Coming in 2016…
- Manuscripts Published by HDRP Staff in 2015
Message from Acting Associate Director, Ann Geiger
January 1, 2016, marks the one-year anniversary of the Healthcare Delivery Research Program (HDRP). In this, our first of what we hope will be quarterly newsletters, we recap some highlights from 2015 and preview several activities that we’ll be pursuing in 2016.
Our initial steps as a program were to establish new mission and vision statements, which can be found on our website. We also organized ourselves into three distinct yet synergistic branches, including the Outcomes Research Branch (ORB), which measures, evaluates, and improves patient experiences; the Health Systems and Interventions Research Branch (HSIRB), which supports research to observe and intervene on contextual factors, such as clinicians, caregivers, payers, and delivery systems; and the Healthcare Assessment Research Branch (HARB), which assesses utilization, diffusion, and population-based outcomes. Ultimately, the goal of these branches is to support a larger portfolio of extramural research and, increasingly, quality-of-care assessments at both the individual and population levels.
During the second half of the year, we focused on assessing opportunities to revitalize our initiatives so they are positioned to meet research and evidence needs over the next decade. We also intensified our efforts to develop funding opportunity announcements that will promote new research directions. Finally, we sought to expand our collaborations within NCI, which increases the visibility and impact of our science and expands our opportunities to integrate health care delivery research into NCI initiatives.
Our priority for 2016 is to continue identifying and acting on the unique ways in which NCI can promote research that addresses the most important questions in health care delivery across the cancer continuum. We plan to pay particular attention to the cross-cutting topics of health disparities, health information technology, patient-reported outcomes, and value.
We have an accomplished and collegial group of dedicated staff who continue to push the boundaries of what is possible in this important area of research. Please take a moment to thank them for their efforts when you have a chance.
It has been a pleasure and an honor for me to serve as the Acting Associate Director for this past year. I and the entire HDRP team are excited about continuing to make progress in advancing innovative research to improve the delivery of cancer-related care.
Integrating Cancer Care Delivery Research into NCORP
The NCI Community Oncology Research Program (NCORP) is a trans-NCI program housed in the Division of Cancer Prevention. NCORP continues NCI's investment in infrastructure that allows cancer patients to access treatment trials, symptom management studies, and other research opportunities in their local community.
Led by HDRP staff, the Division of Cancer Control and Population Sciences worked across NCI to add cancer care delivery research (CCDR) to NCORP. Launched in 2014, the goal of adding this research component was sustained transformation of the cancer delivery system to improve clinical outcomes, enhance patient experiences, and optimize value. Additional background about CCDR can be found in an article published in the Journal of Clinical Oncology earlier this year.
The major focus of the first year of CCDR activities within NCORP was to characterize and build capacity and infrastructure at NCORP Research Bases and Sites, many of which have little experience in this area of research. A CCDR Coordinating Committee of NCORP scientists and clinicians was formed to promote and coordinate scientific collaborations within the network. A CCDR Steering Committee of scientists, clinicians, and patient advocates from NCORP and other organizations was established to review study concepts for scientific merit and feasibility. HDRP staff also worked internally with NCI partners to align the systems and processes established for NCORP clinical trials to accommodate the unique characteristics of this type of research. For example, a CCDR study may look at factors from multiple levels (such as an individual, organization, or system) instead of just at patient outcomes as might be common in clinical trials. Other activities in the first year included reviewing research areas of interest from the sites, drafting research priorities, and developing and disseminating information to characterize CCDR resources and capabilities of the network.
Promoting Patient Reported Outcomes (PRO) Measurement
During the past year, an ever-expanding number of people and efforts have coalesced around the importance of understanding cancer patients’ and survivors’ experiences when assessing quality of care, evaluating new drugs, and tailoring treatments. The following examples illustrate how staff in our Outcomes Research Branch are contributing to progress in this area.
Over the past decade, the NIH has supported the development and evaluation of four state-of-the-science measurement systems that capture person-centered health outcomes (e.g., common disease and treatment-related symptoms, function, health-related quality of life) in clinical and population-based research and in health care delivery settings. These include the Patient Reported Outcomes Measurement Information System® (PROMIS®), the NIH Toolbox for Assessment of Neurological and Behavioral Function (NIH Toolbox®), the Quality of Life Outcomes in Neurological Disorders (Neuro-QoL) and, Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-Me). HealthMeasures, a trans-NIH initiative led by Outcomes Research Branch staff and housed at Northwestern University, provides automated use of these measurement systems, promotes their uptake in the scientific and clinical communities, and transitions toward a sustainable resource that allows for maintenance of these measurement systems into the future. Information about the four systems, their availability, and use can be found at their website.
The Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) is an electronic-based system for patients on cancer clinical trials to self-report symptomatic toxicities such as nausea, fatigue, and neuropathy. It was developed to complement and extend the Common Terminology Criteria for Adverse Events (CTCAE), NCI’s system for clinician grading of treatment-related adverse effects in cancer clinical trials. PRO-CTCAE is applicable in selected cancer clinical trials where a precise description of the symptomatic toxicities experienced by patients is needed to better understand treatment tolerability. ORB staff continue to facilitate work on item validation, interpretation, and integration of PRO-CTCAE in cancer clinical trials and uptake in clinical research.
The SEER-Medicare Health Outcomes Survey (SEER-MHOS) data resource is one of two SEER cancer registry data linkages for patient-reported outcome surveillance. It is a collaboration of the NCI and Centers for Medicare and Medicaid Services (CMS). MHOS is an annual quality improvement survey of Medicare Advantage participants, with beneficiaries sampled, surveyed, and then resurveyed 2 years later on health-related quality of life and other PROs. The current linkage includes over 125,000 MHOS respondents with linked SEER registry information. Data are publicly available upon approved application.
Finally, NCI and CMS have collaborated on the development of the SEER-CAHPS database, which links SEER registry data with the Consumer Assessment of Healthcare Providers and Systems (CAHPS) Medicare survey and Medicare claims (fee-for-service only) data. The CAHPS surveys, which are overseen by the Agency for Healthcare Research and Quality (AHRQ), ask consumers and patients to report on their experiences with health care. SEER-CAHPS provides a rich opportunity for analyses of Medicare beneficiaries' experiences with their care at various stages of the cancer care continuum. A description of this data resource was published earlier this year and plans are underway to provide a public release in the next year or so.
Working for You…
Below are a few highlights of extramural-related activities from the past year. Of course, this is just a sampling of the many activities in which HDRP staff are involved. For more information about our research resources, please visit our website.
Building Research Resources: Expanding Data Linkages
On September 18, 2015, HDRP convened a small meeting of leading researchers with extensive experience using existing health data and performing linkages with cancer registry data. The primary goal of the meeting was to evaluate and prioritize data sources that might be linked to cancer registry data in order to enhance options for health services research. Participants identified priority data sets and suggested several steps that NCI can take in the next couple of years to create new or enhance existing linkages. Participants were also asked to identify future needs to develop and improve data resources that support cancer health services research. HDRP staff have begun to follow-up on several priority areas and will continue to consider directions for moving this area forward in impactful and important ways.
Growing New Areas of Research: HPV Vaccination
As HPV vaccination becomes an increasingly prominent topic for cervical cancer screening prevention, HDRP is engaging in more research activities in this area. Late in 2014, HDRP funded one-year grant supplements to 18 Cancer Centers to conduct an environmental scan of HPV vaccine uptake in pediatric care settings. These supplements are part of a larger effort that we, along with CDC's Division of Cancer Prevention and Control, are undertaking to systematically bring together NCI-Designated Cancer Centers, CDC programs, and state and local health departments and their immunization programs to improve HPV vaccination update and conduct research on HPV vaccines within the context of primary care.
Identifying Research Priorities: Informal Cancer Caregiving
On May 4-5, 2015, the NCI and the National Institute of Nursing Research co-sponsored a 2-day workshop with invited stakeholders to share expertise about the state of the science of informal cancer caregiving for adult cancer patients and to identify gaps in the science from the perspectives of patients, caregivers, health care providers, and researchers. The workshop focused on cancer caregiver burden and the reciprocal relationship that exists between patients’ and caregivers’ physical and emotional responses to illness. Participants were challenged to consider the state of the current science of informal cancer caregiving across the care continuum, identify knowledge gaps, and propose short- and long-term recommendations to fill identified gaps. Many ideas were generated for moving this area forward and we will continue to discuss these important issues in the coming year.Advancing Careers: New Panel of CRN Scholars
The Cancer Research Network (CRN) is an NCI-funded cooperative agreement (U24) to support and facilitate cancer research based in non-profit integrated health care delivery settings. Grant funding supports data development and research infrastructure at eight participating institutions that provide care for approximately 6 million people. A hallmark feature of the CRN is the CRN Scholars Program – a 26-month training program of early-career investigators. Through this mentorship program, scholars are expected to develop their own R01 applications and/or first-author peer-reviewed publications. A new group of scholars was selected for the 2015 cohort, which began in March. We expect many exceptional research proposals and manuscripts from this great group of talented investigators in the years ahead!
Current Funding Opportunities
Program Announcements Related to Health Care Delivery Research
The table below provides a snapshot of currently open funding announcements related to health care delivery research across the Division of Cancer Control and Population Sciences. For a full list of open announcements, visit the DCCPS website.
|Title||Announcement # / Mechanism(s)||Expiration Date|
|End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses||PA-15-324 (R01)
|January 8, 2019|
|Examination of Survivorship Care Planning Efficacy and Impact||PA-16-012 (R01)
|January 8, 2019|
|Advancing Interventions to Improve Medication Adherence||PA-14-334 (R01)
|January 8, 2018|
|Core Infrastructure and Methodological Research for Cancer||PAR-15-104 (U01)||March 11, 2017|
|Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests||PAR-15-108 (U01)||September 22, 2017|
|Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care||PA-14-114 (R01)||May 8, 2017|
|Research to Characterize and Reduce Stigma to Improve Health||PA-13-246 (R21)
|September 8, 2016|
|Innovative Research Methods: Prevention and Management of Symptoms in Chronic Illness||PA-13-165 (R01)
|May 8, 2016|
Provocative Questions RFA
HDRP is participating in the Provocative Questions (PQ) initiative, which features 12 important questions intended to stimulate specific areas of cancer research that are deemed understudied, neglected, paradoxical, or have been difficult to address in the past. Provocative Question 12 (PQ-12) is the most relevant to researchers interested in health care delivery issues and seeks hypothesis-driven studies that explicitly examine how physicians and/or health systems can be induced to diminish delivery of ineffective or unproven cancer care. The Trans-NIH PQ-12 Team is led by Ann Geiger, and many HDRP staff are involved in the process. Applications are due June 29, 2016, or October 28, 2016.
Coming in 2016…
Here is a sampling of activities that we are looking forward to working on this year!
National Survey of Precision Medicine in Cancer Treatment
NCI, in collaboration with the National Human Genome Research Institute and the American Cancer Society, will be fielding the National Survey of Precision Medicine in Cancer Treatment in 2016. This nationally representative survey of medical oncologists will look at medical oncologists’ experiences, attitudes, and recommendations concerning genomic tests; determine the prevalence of genomic testing in oncology; and identify facilitators and barriers in the integration of genomic testing into oncology. The findings from the survey will be used to identify future research needs and to help inform the development of educational materials for providers and patients.
National Health Interview Survey (NHIS) Cancer Control Supplement (CCS)
The National Health Interview Survey (NHIS) is the premier, population-based, general health survey in the United States, which is fielded annually to a nationally representative sample of households through in-person interviews. In 2015, NCI, in collaboration with CDC’s Division of Cancer Prevention and Control, fielded a 20-minute Cancer Control Supplement as part of the NHIS. The 2015 NHIS CCS will be the first opportunity to assess the impact of changes to reimbursement structures on cancer control. The survey will also provide population-level data about uptake of new lung cancer screening guidelines. Additionally, new items were added to assess the use of cancer screening tests, new tobacco products, indoor tanning, analgesics, genetic counseling, as well as walking and family history of cancer. Public use data from this survey will be available in June 2016.
Health Care Teams
HDRP staff are working to promote increased knowledge of how health care teams affect the delivery of cancer care and to integrate this knowledge into cancer care delivery research. New partnerships with stakeholders that historically have not worked with NCI are being formed to examine evidence of how teams can improve clinical outcomes for cancer patients to establish the groundwork for publications and funding opportunities that influence and advance the science of team performance in cancer care. Upcoming activities in this area over the next year include the Healthcare Teams Cyber Discussion Series, which is designed to explore how health care teams use health information technology (HIT) to improve cancer care delivery, and the NCI-ASCO Teams in Cancer Care Delivery Workshop, which will result in the publication of a supplement on health care teams through the Journal of Oncology Practice.
Manuscripts Published by HDRP Staff in 2015
Baird K, Comis LE, Joe GO, Steinberg SM, Hakim FT, Rose JJ, Mitchell SA, Pavletic SZ, Figg WD, Yao L, Flanders KC, Takebe N, Sarantopoulos S, Booher S, Cowen EW. Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease. Biol Blood Marrow Transplant 2015 Jun;21(6):1083-90. [View Abstract]
Barile JP, Mitchell SA, Thompson WW, Zack MM, Reeve BB, Cella D, Smith AW. Patterns of Chronic Conditions and Their Associations With Behaviors and Quality of Life, 2010. Prev Chronic Dis 2015 Dec 17;12:E222. doi: 10.5888/pcd12.150179. [View Abstract]
Beaber EF, Kim JJ, Schapira MM, Tosteson AN, Zauber AG, Geiger AM, Kamineni A, Weaver DL, Tiro JA; Population-based Research Optimizing Screening through Personalized Regimens Consortium. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening. J Natl Cancer Inst 2015 May 7;107(6):djv120. Print 2015 Jun. [View Abstract]
Bennett AV, Reeve BB, Basch EM, Mitchell SA, Meeneghan M, Battaglini CL, Smith-Ryan AE, Phillips B, Shea TC, Wood WA. Evaluation of pedometry as a patient-centered outcome in patients undergoing hematopoietic cell transplant (HCT): a comparison of pedometry and patient reports of symptoms, health, and quality of life. Qual Life Res 2015 Nov 17. [Epub ahead of print] [View Abstract]
Berger AM, Mitchell SA, Jacobsen PB, Pirl WF. Screening, evaluation, and management of cancer-related fatigue: Ready for implementation to practice? CA Cancer J Clin 2015 May-Jun;65(3):190-211. Review. [View Abstract]
Blake KD, Ottenbacher AJ, Finney Rutten LJ, Grady MA, Kobrin SC, Jacobson RM, Hesse BW. Predictors of human papillomavirus awareness and knowledge in 2013: gaps and opportunities for targeted communication strategies. Am J Prev Med 2015 Apr;48(4):402-10. [View Abstract]
Blanch-Hartigan D, Chawla N, Beckjord EI, Forsythe LP, de Moor JS, Hesse BW, Arora NK. Cancer survivors' receipt of treatment summaries and implications for patient-centered communication and quality of care. Patient Educ Couns 2015 Oct;98(10):1274-9. [View Abstract]
Bremner KE, Krahn MD, Warren JL, Hoch JS, Barrett MJ, Liu N, Barbera L, Yabroff KR. An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data. Palliat Med 2015 Dec;29(10):918-28. [View Abstract]
Breslau ES, Weiss ES, Williams A, Burness A, Kepka D. The implementation road: engaging community partnerships in evidence-based cancer control interventions. Health Promot Pract 2015 Jan;16(1):46-54. [View Abstract]
Casagrande S, Cowie C, Yanovski S, Smith AW, Ballard-Barbash R, Lee R, Staten M. (2015). Glucose testing and lifestyle counseling by primary care physicians in the United States. Journal of Obesity and Overweight 1(2), 1-7.
Coronado GD, Retecki S, Schneider J, Taplin SH, Burdick T, Green BB. Recruiting community health centers into pragmatic research: Findings from STOP CRC. Clin Trials 2015 Sep 29. pii: 1740774515608122. [Epub ahead of print] [View Abstract]
Curtis LM, Datiles MB 3rd, Steinberg SM, Mitchell SA, Bishop RJ, Cowen EW, Mays J, McCarty JM, Kuzmina Z, Pirsl F, Fowler DH, Gress RE, Pavletic SZ. Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice. Haematologica 2015 Sep;100(9):1228-36. [View Abstract]
Davidoff AJ, Hill SC, Bernard D, Yabroff KR. The Affordable Care Act and Expanded Insurance Eligibility Among Nonelderly Adult Cancer Survivors. J Natl Cancer Inst 2015 Jul 1;107(9). pii: djv181. Print 2015 Sep. [View Abstract]
de Moor JS, Alfano CM, Breen N, Kent EE, Rowland J. Applying evidence from economic evaluations to translate cancer survivorship research into care. J Cancer Surviv 2015 Sep;9(3):560-6. [View Abstract]
DeRouen MC, Smith AW, Tao L, Bellizzi KM, Lynch CF, Parsons HM, Kent EE, Keegan TH; AYA HOPE Study Collaborative Group. Cancer-related information needs and cancer's impact on control over life influence health-related quality of life among adolescents and young adults with cancer. Psychooncology 2015 Sep;24(9):1104-15. [View Abstract]
Deziel NC, Colt JS, Kent EE, Gunier RB, Reynolds P, Booth B, Metayer C, Ward MH. Associations between self-reported pest treatments and pesticide concentrations in carpet dust. Environ Health 2015 Mar 25;14:27. doi: 10.1186/s12940-015-0015-x. [View Abstract]
Drahos J, Ricker W, Parsons R, Pfeiffer RM, Warren JL, Cook MB. Metabolic syndrome increases risk of Barrett esophagus in the absence of gastroesophageal reflux: an analysis of SEER-Medicare Data. J Clin Gastroenterol 2015 Apr;49(4):282-8. doi: 10.1097/MCG.0000000000000119. [View Abstract]
Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, Atkinson TM, Bennett AV, Denicoff AM, O'Mara AM, Li Y, Clauser SB, Bryant DM, Bearden JD 3rd, Gillis TA, Harness JK, Siegel RD, Paul DB, Cleeland CS, Schrag D, Sloan JA, Abernethy AP, Bruner DW, Minasian LM, Basch E; National Cancer Institute PRO-CTCAE Study Group. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol 2015 Nov 1;1(8):1051-9. doi: 10.1001/jamaoncol.2015.2639. [View Abstract]
Enewold L, Geiger AM, Zujewski J, Harlan LC. Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy. Breast Cancer Res Treat 2015 May;151(1):149-56. [View Abstract]
Enewold L, Harlan LC, Stevens JL, Sharon E. Thyroid cancer presentation and treatment in the United States. Ann Surg Oncol 2015;22(6):1789-97. [View Abstract]
Enewold L, Harlan LC, Tucker T, McKenzie S. Pancreatic cancer in the USA: persistence of undertreatment and poor outcome. J Gastrointest Cancer 2015 Mar;46(1):9-20. doi: 10.1007/s12029-014-9668-x. [View Abstract]
Fedewa SA, de Moor JS, Ward EM, DeSantis CE, Goding Sauer A, Smith RA, Jemal A. Mammography Use and Physician Recommendation After the 2009 U.S. Preventive Services Task Force Breast Cancer Screening Recommendations. Am J Prev Med 2015 Dec 14. pii: S0749-3797(15)00687-X. [Epub ahead of print] [View Abstract]
Friedman EL, Chawla N, Morris PT, Castro KM, Carrigan AC, Das IP, Clauser SB. Assessing the Development of Multidisciplinary Care: Experience of the National Cancer Institute Community Cancer Centers Program. J Oncol Pract 2014 Oct 21. pii: JOP.2014.001535. [Epub ahead of print] [View Abstract]
Gard CC, Aiello Bowles EJ, Miglioretti DL, Taplin SH, Rutter CM. Misclassification of Breast Imaging Reporting and Data System (BI-RADS) Mammographic Density and Implications for Breast Density Reporting Legislation. Breast J 2015 Sep-Oct;21(5):481-9. [View Abstract]
Guy GP Jr, Machlin SR, Ekwueme DU, Yabroff KR. Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. Am J Prev Med 2015 Feb;48(2):183-7. [View Abstract]
Guy GP Jr, Yabroff KR, Ekwueme DU, Virgo KS, Han X, Banegas MP, Soni A, Zheng Z, Chawla N, Geiger AM. Healthcare Expenditure Burden Among Non-elderly Cancer Survivors, 2008-2012. Am J Prev Med 2015 Dec;49(6 Suppl 5):S489-97. doi: 10.1016/j.amepre.2015.09.002. [View Abstract]
Halpern MT, Spain P, Holden DJ, Stewart A, McNamara EJ, Gay G, Das IP, Clauser S. Improving quality of cancer care at community hospitals: impact of the National Cancer Institute Community Cancer Centers Program pilot. J Oncol Pract 2013 Nov;9(6):e298-304. [View Abstract]
[No authors listed] Han X, Lin CC, Li C, de Moor JS, Rodriguez JL, Kent EE and Forsythe LP. Association between serious psychological distress and health care use and expenditures by cancer history. Cancer. 2015;121:614-622. Cancer 2015 Nov 1;121(21):3925-6. [Look up in PubMed]
Han X, Robin Yabroff K, Guy GP Jr, Zheng Z, Jemal A. Has recommended preventive service use increased after elimination of cost-sharing as part of the Affordable Care Act in the United States? Prev Med 2015 Sep;78:85-91. [View Abstract]
Harlan LC, Eisenstein J, Russell MC, Stevens JL, Cardona K. Gastrointestinal stromal tumors: treatment patterns of a population-based sample. J Surg Oncol 2015 May;111(6):702-7. doi: 10.1002/jso.23879. [View Abstract]
Harlan LC, Parsons HM, Wiggins CL, Stevens JL, Patt YZ. Treatment of hepatocellular carcinoma in the community: disparities in standard therapy. Liver Cancer 2015 Mar;4(1):70-83. doi: 10.1159/000367729. [View Abstract]
Harlan LC, Warren JL. Global survival patterns: potential for cancer control. Lancet 2015 Mar 14;385(9972):926-8. [Look up in PubMed]
Irvin VL, Breen N, Meissner HI, Liu B, Kaplan RM. Non-normal Screening Mammography Results, Lumpectomies, and Breast Cancer Reported by California Women, 2001-2009. Womens Health Issues 2015 Jul-Aug;25(4):331-40. [View Abstract]
Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers ME. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 2015 Mar;21(3):389-401.e1. [View Abstract]
Jensen RE, Potosky AL, Reeve BB, Hahn E, Cella D, Fries J, Smith AW, Keegan TH, Wu XC, Paddock L, Moinpour CM. Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients. Qual Life Res 2015 Oct;24(10):2333-44. [View Abstract]
Kent EE, Ambs A, Mitchell SA, Clauser SB, Smith AW, Hays RD. Health-related quality of life in older adult survivors of selected cancers: data from the SEER-MHOS linkage. Cancer 2015 Mar 1;121(5):758-65. [View Abstract]
Kent EE, Breen N, Lewis DR, de Moor JS, Smith AW, Seibel NL. US trends in survival disparities among adolescents and young adults with non-Hodgkin lymphoma. Cancer Causes Control 2015 Aug;26(8):1153-62. [View Abstract]
Kent EE, Mitchell SA, Castro KM, DeWalt DA, Kaluzny AD, Hautala JA, Grad O, Ballard RM, McCaskill-Stevens WJ, Kramer BS, Clauser SB. Cancer Care Delivery Research: Building the Evidence Base to Support Practice Change in Community Oncology. J Clin Oncol 2015 Aug 20;33(24):2705-11. [View Abstract]
Kent EE, Prestin A, Gaysynsky A, Galica K, Rinker R, Graff K, Chou WY. "Obesity is the New Major Cause of Cancer": Connections Between Obesity and Cancer on Facebook and Twitter. J Cancer Educ 2015 Apr 14. [Epub ahead of print] [View Abstract]
Kirsch M, Mitchell SA, Dobbels F, Stussi G, Basch E, Halter JP, De Geest S. Linguistic and content validation of a German-language PRO-CTCAE-based patient-reported outcomes instrument to evaluate the late effect symptom experience after allogeneic hematopoietic stem cell transplantation. Eur J Oncol Nurs 2015 Feb;19(1):66-74. [View Abstract]
Klabunde CN, Shapiro JA, Kobrin S, Nadel MR, Zapka JM. Colorectal Cancer Screening in US Seniors Ages 76-84 Years. J Community Health 2015 Aug;40(4):769-79. doi: 10.1007/s10900-015-9998-z. [View Abstract]
Kobrin S, Ferrer R, Meissner H, Tiro J, Hall K, Shmueli-Blumberg D, Rothman A. Use of Health Behavior Theory in Funded Grant Proposals: Cancer Screening Interventions as a Case Study. Ann Behav Med 2015 Dec;49(6):809-18. doi: 10.1007/s12160-015-9714-3. [View Abstract]
Lam CJ, Curtis RE, Dores GM, Engels EA, Caporaso NE, Polliack A, Warren JL, Young HA, Levine PH, Elmi AF, Fraumeni JF Jr, Tucker MA, Morton LM. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma. J Clin Oncol 2015 Oct 1;33(28):3096-104. [View Abstract]
Leach CR, Weaver KE, Aziz NM, Alfano CM, Bellizzi KM, Kent EE, Forsythe LP, Rowland JH. The complex health profile of long-term cancer survivors: prevalence and predictors of comorbid conditions. J Cancer Surviv 2015 Jun;9(2):239-51. [View Abstract]
Lee SJ, Wolff D, Kitko C, Koreth J, Inamoto Y, Jagasia M, Pidala J, Olivieri A, Martin PJ, Przepiorka D, Pusic I, Dignan F, Mitchell SA, Lawitschka A, Jacobsohn D, Hall AM, Flowers ME, Schultz KR, Vogelsang G, Pavletic S. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report. Biol Blood Marrow Transplant 2015 Jun;21(6):984-99. [View Abstract]
Leyva B, Nguyen AB, Allen JD, Taplin SH, Moser RP. Is religiosity associated with cancer screening? Results from a national survey. J Relig Health 2015 Jun;54(3):998-1013. doi: 10.1007/s10943-014-9843-1. [View Abstract]
Leyva B, Persoskie A, Ottenbacher A, Hamilton JG, Allen JD, Kobrin SC, Taplin SH. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey. J Cancer Educ 2015 Oct 26. [Epub ahead of print] [View Abstract]
Litzelman K, Kent EE, Rowland JH. Social factors in informal cancer caregivers: The interrelationships among social stressors, relationship quality, and family functioning in the CanCORS data set. Cancer 2016 Jan 15;122(2):278-286. [View Abstract]
Murphy CC, Harlan LC, Lund JL, Lynch CF, Geiger AM. Patterns of Colorectal Cancer Care in the United States: 1990-2010. J Natl Cancer Inst 2015 Jul 23;107(10). pii: djv198. Print 2015 Oct. [View Abstract]
Murphy CC, Harlan LC, Warren JL, Geiger AM. Race and Insurance Differences in the Receipt of Adjuvant Chemotherapy Among Patients With Stage III Colon Cancer. J Clin Oncol 2015 Aug 10;33(23):2530-6. [View Abstract]
Nass SJ, Beaupin LK, Demark-Wahnefried W, Fasciano K, Ganz PA, Hayes-Lattin B, Hudson MM, Nevidjon B, Oeffinger KC, Rechis R, Richardson LC, Seibel NL, Smith AW. Identifying and addressing the needs of adolescents and young adults with cancer: summary of an Institute of Medicine workshop. Oncologist 2015 Feb;20(2):186-95. Review. [View Abstract]
Onega T, Goldman LE, Walker RL, Miglioretti DL, Buist DS, Taplin S, Geller BM, Hill DA, Smith-Bindman R. Facility Mammography Volume in Relation to Breast Cancer Screening Outcomes. J Med Screen 2015 Aug 11. pii: 0969141315595254. [Epub ahead of print] [View Abstract]
Onukwugha E, Petrelli NJ, Castro KM, Gardner JF, Jayasekera J, Goloubeva O, Tan MT, McNamara EJ, Zaren HA, Asfeldt T, Bearden JD 3rd, Salner AL, Krasna MJ, Prabhu Das I, Clauser SB. Impact of Multidisciplinary Care on Processes of Cancer Care: A Multi-Institutional Study. J Oncol Pract 2015 Oct 13. pii: JOP.2015.004200. [Epub ahead of print] [View Abstract]
Palmer NR, Weaver KE, Hauser SP, Lawrence JA, Talton J, Case LD, Geiger AM. Disparities in barriers to follow-up care between African American and White breast cancer survivors. Support Care Cancer 2015 Nov;23(11):3201-9. [View Abstract]
Parsons HM, Enewold LR, Banks R, Barrett MJ, Warren JL. Creating a National Provider Identifier (NPI) to Unique Physician Identification Number (UPIN) Crosswalk for Medicare Data. Med Care 2015 Dec 17. [Epub ahead of print] [View Abstract]
Parsons HM, Harlan LC, Schmidt S, Keegan TH, Lynch CF, Kent EE, Wu XC, Schwartz SM, Chu RL, Keel G, Smith AW; AYA HOPE Collaborative Group. Who Treats Adolescents and Young Adults with Cancer? A Report from the AYA HOPE Study. J Adolesc Young Adult Oncol 2015 Sep 1;4(3):141-150. [View Abstract]
Phillips SM, Padgett LS, Leisenring WM, Stratton KK, Bishop K, Krull KR, Alfano CM, Gibson TM, de Moor JS, Hartigan DB, Armstrong GT, Robison LL, Rowland JH, Oeffinger KC, Mariotto AB. Survivors of childhood cancer in the United States: prevalence and burden of morbidity. Cancer Epidemiol Biomarkers Prev 2015 Apr;24(4):653-63. doi: 10.1158/1055-9965.EPI-14-1418. [View Abstract]
Pine SR, Mechanic LE, Enewold L, Bowman ED, Ryan BM, Cote ML, Wenzlaff AS, Loffredo CA, Olivo-Marston S, Chaturvedi AK, Caporaso NE, Schwartz AG, Harris CC. Differential Serum Cytokine Levels and Risk of Lung Cancer between African and European Americans. Cancer Epidemiol Biomarkers Prev 2015 Dec 28. pii: cebp.0378.2015. [Epub ahead of print] [View Abstract]
Prince P, Mitchell SA, Wehrlen L, Childs R, Savani B, Yang L, Bevans M. Spiritual Well-Being in Hispanic and Non-Hispanic Survivors of Allogeneic Hematopoietic Stem Cell Transplantation. J Psychosoc Oncol 2015 Nov-Dec;33(6):635-54. doi: 10.1080/07347332.2015.1082167. [View Abstract]
Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, Fahey T, Grassi L, Grunfeld E, Gupta S, Hamilton W, Hiom S, Hunter D, Lyratzopoulos G, Macleod U, Mason R, Mitchell G, Neal RD, Peake M, Roland M, Seifert B, Sisler J, Sussman J, Taplin S, Vedsted P, Voruganti T, Walter F, Wardle J, Watson E, Weller D, Wender R, Whelan J, Whitlock J, Wilkinson C, de Wit N, Zimmermann C. The expanding role of primary care in cancer control. Lancet Oncol 2015 Sep;16(12):1231-72. Review. [View Abstract]
Sabatino SA, White MC, Thompson TD, Klabunde CN; Centers for Disease Control and Prevention (CDC). Cancer screening test use - United States, 2013. MMWR Morb Mortal Wkly Rep 2015 May 8;64(17):464-8. [View Abstract]
Schonberg MA, Breslau ES. Mammography screening for women aged 70 and older: at a crossroads. J Am Geriatr Soc 2015 Jan;63(1):170-2. [Look up in PubMed]
Shnorhavorian M, Harlan LC, Smith AW, Keegan TH, Lynch CF, Prasad PK, Cress RD, Wu XC, Hamilton AS, Parsons HM, Keel G, Charlesworth SE, Schwartz SM; AYA HOPE Study Collaborative Group. Fertility preservation knowledge, counseling, and actions among adolescent and young adult patients with cancer: A population-based study. Cancer 2015 Oct 1;121(19):3499-506. [View Abstract]
Siegel RD, Castro KM, Eisenstein J, Stallings H, Hegedus PD, Bryant DM, Kadlubek PJ, Clauser SB. Quality improvement in the national cancer institute community cancer centers program: the quality oncology practice initiative experience. J Oncol Pract 2015 Mar;11(2):e247-54. [View Abstract]
Smith AW, Mitchell SA, De Aguiar CK, Moy C, Riley WT, Wagster MV, Werner E. (2015). News from the NIH: Person-centered outcomes measurement: NIH-supported measurement systems to evaluate self-assessed health, functional performance, and symptomatic toxicity. Translational behavioral medicine 1-5. doi:10.1007/s13142-015-0345-9. [View Abstract]
Smith TG, Castro KM, Troeschel AN, Arora NK, Lipscomb J, Jones SM, Treiman KA, Hobbs C, McCabe RM, Clauser SB. The rationale for patient-reported outcomes surveillance in cancer and a reproducible method for achieving it. Cancer 2015 Nov 30. [Epub ahead of print] [View Abstract]
Sohl SJ, Borowski LA, Kent EE, Smith AW, Oakley-Girvan I, Rothman RL, Arora NK. Cancer survivors' disclosure of complementary health approaches to physicians: the role of patient-centered communication. Cancer 2015 Mar 15;121(6):900-7. [View Abstract]
Srinivasan S, Moser RP, Willis G, Riley W, Alexander M, Berrigan D, Kobrin S. Small is essential: importance of subpopulation research in cancer control. Am J Public Health 2015 Jul;105 Suppl 3:S371-3. [Look up in PubMed]
Srinivasan S, Moser RP, Willis G, Riley W, Alexander M, Berrigan D, Kobrin S. Small is essential: importance of subpopulation research in cancer control. Am J Public Health 2015 Jul;105 Suppl 3:S371-3. [Look up in PubMed]
Taber JM, Klein WM, Ferrer RA, Kent EE, Harris PR. Optimism and Spontaneous Self-affirmation are Associated with Lower Likelihood of Cognitive Impairment and Greater Positive Affect among Cancer Survivors. Ann Behav Med 2015 Oct 23. [Epub ahead of print] [View Abstract]
Taplin SH, Weaver S, Chollette V, Marks LB, Jacobs A, Schiff G, Stricker CT, Bruinooge SS, Salas E. Teams and teamwork during a cancer diagnosis: interdependency within and between teams. J Oncol Pract 2015 May;11(3):231-8. [View Abstract]
Taplin SH, Weaver S, Salas E, Chollette V, Edwards HM, Bruinooge SS, Kosty MP. Reviewing cancer care team effectiveness. J Oncol Pract 2015 May;11(3):239-46. [View Abstract]
Tatalovich Z, Zhu L, Rolin A, Lewis DR, Harlan LC, Winn DM. Geographic disparities in late stage breast cancer incidence: results from eight states in the United States. Int J Health Geogr 2015 Oct 24;14:31. doi: 10.1186/s12942-015-0025-5. [View Abstract]
Warren JL, Butler EN, Stevens J, Lathan CS, Noone AM, Ward KC, Harlan LC. Receipt of chemotherapy among medicare patients with cancer by type of supplemental insurance. J Clin Oncol 2015 Feb 1;33(4):312-8. [View Abstract]
Warren JL, Yabroff KR. Challenges and opportunities in measuring cancer recurrence in the United States. J Natl Cancer Inst 2015 May 12;107(8). pii: djv134. Print 2015 Aug. [View Abstract]
Weinfurt KP, Lin L, Bruner DW, Cyranowski JM, Dombeck CB, Hahn EA, Jeffery DD, Luecht RM, Magasi S, Porter LS, Reese JB, Reeve BB, Shelby RA, Smith AW, Willse JT, Flynn KE. Development and Initial Validation of the PROMIS(®) Sexual Function and Satisfaction Measures Version 2.0. J Sex Med 2015 Sep;12(9):1961-74. [View Abstract]
Wood WA, Deal AM, Bennett AV, Mitchell SA, Abernethy AP, Basch E, Bailey C, Reeve BB. Comparison of seven-day and repeated 24-hour recall of symptoms in the first 100 days after hematopoietic cell transplantation. J Pain Symptom Manage 2015 Mar;49(3):513-20. [View Abstract]
Wu XC, Prasad PK, Landry I, Harlan LC, Parsons HM, Lynch CF, Smith AW, Hamilton AS, Keegan TH; AYA HOPE Study Collaborative Group. Impact of the AYA HOPE Comorbidity Index on Assessing Health Care Service Needs and Health Status among Adolescents and Young Adults with Cancer. Cancer Epidemiol Biomarkers Prev 2015 Dec;24(12):1844-9. [View Abstract]
Yabroff KR, Dowling EC, Guy GP Jr, Banegas MP, Davidoff A, Han X, Virgo KS, McNeel TS, Chawla N, Blanch-Hartigan D, Kent EE, Li C, Rodriguez JL, de Moor JS, Zheng Z, Jemal A, Ekwueme DU. Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors. J Clin Oncol 2015 Dec 7. pii: JCO620468. [Epub ahead of print] [View Abstract]
Zuo RC, Naik HB, Steinberg SM, Baird K, Mitchell SA, Kuzmina Z, Pavletic SZ, Cowen EW. Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease. JAMA Dermatol 2015 Jan;151(1):23-32. doi: 10.1001/jamadermatol.2014.1550. [View Abstract]
Last Updated: 25 Oct 2018